Pharmacokinetics of the opioid antagonist N-methylnaltrexone and evaluation of its effects on gastrointestinal tract function in horses treated or not treated with morphine

American Journal of Veterinary Research

Volumn 67, Issue 6, 2006, Pages 998-1004

  Boscan, Pedro ^a   Van Hoogmoed, Linda M ^a   Pypendop, Bruno H ^a   Farver, Thomas B ^a   Snyder, Jack R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; MORPHINE; OPIATE ANTAGONIST;

ARTICLE; BLOOD SAMPLING; COMPARTMENT MODEL; CONTROLLED STUDY; DEFECATION; DISTRIBUTION VOLUME; DRUG ANTAGONISM; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EFFECT; FECES ANALYSIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT FUNCTION; HORSE; INTESTINE TRANSIT TIME; MALE; NONHUMAN; SCORING SYSTEM; STEADY STATE;

ANALGESICS, OPIOID; ANIMALS; DRUG INTERACTIONS; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; HORSES; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; QUATERNARY AMMONIUM COMPOUNDS;

ANIMALIA; EQUIDAE;

EID: 33745642426     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.6.998     Document Type: Article

References (32)

1. Bueno L, Fioramonti J. Action of opiates on gastrointestinal function. Baillieres Clin Gastroenterol 1988;1123-139.
2. De Luca A, Coupar IM. Insights into opioid action in the intestinal tract. Pharmacol Ther 1996;69:103-115.
3. Yuan CS, Foss JF, O'Connor M, et al. Effects of enteric-coated methylualtrexone in preventing opioid-induced delay in oral-cecal transit time. Clin Pharmacol Ther 2000;67:398-404.
4. Boscan PL, Van Hoogmoed LM, Farver TB, et, al. Evaluation of the effect of the opioid agonist morphine on gastrointestinal tract function in horses. Am J Vet Res 2006;67:992-997.
5. Senior JM, Pinchbeck GL, Dugdale AH, et al. Retrospective study of the risk factors and prevalence of colic in horses after orthopaedic surgery. Vet Rec 2004;155:321-325.
6. Akca O, Doufas AG, Sessler DI. Use of selective opiate receptor inhibitors to prevent postoperative ileus. Minerva Anestesiol 2002;68:162-165.
7. Choi YS, Billings JA. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related onstipation. J Pain Symptom Manage 2002;24:71-90.
8. Russell J, Bass P, Goldberg LI, et al. Antagonism of gut, but not central effects of morphine with quaternary narcotic antgonists. Eur J Pharmacol 1982;78:255-261.
9. Yuan CS, Foss JF, O'Connor M, et al. Methyinaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther 1996;59:469-475.
10. Greenwood-Van Meerveld B, Gardner CJ, Little PJ, et al. Preclinical studies of opioids and opioid antagonists on gastrointestinal function. Neurogastroenterol Motil 2004;16(suppl 2):46-53.
11. Schmidt WK. Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist. Am J Surg 2001;182:27S-38S.
12. Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003;63:649-671.
13. Foss JF. A review of the potential role of methylnaltrexone in opioid bowel dysfunction. Am J Surg 2001;182:19S-26S.
14. Yuan Y, Chandler MJ, Foreman RD, et al. Effects of abdomina or cardiopulmonary sympathetic afferents on upper cervical inspiratory neurons. Am J Physiol 2000;278:Rl289-Rl295.
15. van Hoogmoed LM, Boscan PL. In vitro evaluation of the effect of the opioid antagonist N-methylnattrexone on motility of the equine jejunum and pelvic flexure. Equine Vet J 2005;37:325-328.
16. Gibaldi M, Perrier D. Multicompartment models. In: Gibaldi M, ed, Pharmacokinetics. New York: Marcell Dekker Inc, 1982;45-109.
17. Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-175.
18. Lippold BS, Hildebrand J, Straub R. Tegaserod (HTF 919) stimulates gut motility in normal horses. Equine Vet J 2004;36:622-627.
19. Teixeira Neto FJ, McDonell WN, Black WD, et al. Effects of a muscarinic type-2 antagonist on cardiorespiratory function and intestinal transit in horses anesthetized with halothane and xylazine. Am J Vet Res 2004;65:464-472.
20. Singh S, McDonell WN, Young SS, et al. Cardiopulmonary and gastrointestinal motility effects of xylazine/ketamine-induced anesthesia in horses previously treated with glycopyrrolate. Am J Vet Res 1996;57:1762-1770.
21. Singh S, Young SS, McDonell WN, et al. Modification of cardiopulmonary and intestinal motility effects of xylazine with glycopyrrolate in horses. Can J Vet Res 1997;61:99-107.
22. Yuan CS, Foss JF, Moss J. Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine. Eur J Pharmacol 1995;276:107-111.
23. Yuan CS, Foss JF, O'Connor M, et al. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study. Pain 1999;83:631-635.
24. Dodman NH, Shuster L, Court MH, et al. Investigation into the use of narcotic antagonists in the treatment of a stereotypic behavior pattern (crib-biting) in the horse. Am J Vet Res 987;48:311-319.
25. Foss JF, O'Connor MF, Yuan CS, et al. Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic study. J Clin Pharmacol 1997;37:25-30.
26. Stephenson J. Methylnaltrexone reverses opioid-induced constipation. Lancet Oncol 2002;3:202.
27. Taguchi A, Sharma N, Saleem RM, et al. Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med 2001;345:935-940.
28. Wolff BG, Michelassi F, Gerkin TM, et al. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg 2004;240:728-734.
29. Kaufman PN, Krevsky B, Malmud LS, et al. Role of opiate receptors in the regulation of colonic transit. Gastroenterology 1988;94:1351-1356.
30. Steffey EP, Eisele JH, Baggot JD, et al. influence of inhaled anesthetics on the pharmacokinetics and pharmacodynamics of morphine. Anesth AnaIg 1993;77:346-351.
31. Steffey EP, Eisele JH, Baggot JD. Interactions of morphine and isoflurane in horses. Am J Vet Res 2003;64:166-175.
32. Margaritis J, Coupar IM, Bentley GA. Studies to determine whether there is tolerance or cross-tolerance to the antisecretory effect of morphine and clonidine in the rat intestine. J Pharm Pharmacol 1991;43:655-658.